ERBB2 and breast carcinoma: In comparison with those consistently classified as basal-like (n = 46), the tumors clustered as ERBB2 (n = 12) showed a lower average expression in KRT17, KRT5 and especially GABRP, which has been reported to be associated with ER-/HER2- breast cancers [18].